Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
|
|
16.
|
|
|
17.
|
Pre-clinical characterization of Dacomitinib (PF-00299804), an irreversible pan-ErbB inhibitor, combined with ionizing radiation for head and neck squamous cell carcinoma. [electronic resource] by
- Williams, Justin P
- Kim, Inki
- Ito, Emma
- Shi, Wei
- Yue, Shijun
- Siu, Lillian L
- Waldron, John
- O'Sullivan, Brian
- Yip, Kenneth W
- Liu, Fei-Fei
Producer: 20150120
In:
PloS one vol. 9
Availability: No items available.
|
|
18.
|
|
|
19.
|
MiR-449a promotes breast cancer progression by targeting CRIP2. [electronic resource] by
- Shi, Wei
- Bruce, Jeff
- Lee, Matthew
- Yue, Shijun
- Rowe, Matthew
- Pintilie, Melania
- Kogo, Ryunosuke
- Bissey, Pierre-Antoine
- Fyles, Anthony
- Yip, Kenneth W
- Liu, Fei-Fei
Producer: 20170131
In:
Oncotarget vol. 7
Availability: No items available.
|
|
20.
|
Benzethonium chloride: a novel anticancer agent identified by using a cell-based small-molecule screen. [electronic resource] by
- Yip, Kenneth W
- Mao, Xinliang
- Au, P Y Billie
- Hedley, David W
- Chow, Sue
- Dalili, Shadi
- Mocanu, Joseph D
- Bastianutto, Carlo
- Schimmer, Aaron
- Liu, Fei-Fei
Producer: 20061205
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 12
Availability: No items available.
|